Furthermore, the diagnostic effectiveness of YBX1, MED8, and KPNA2 in the NASH cohort was evaluated using ROC analysis, revealing their exceptional performance with area under the curve (AUC) values of 0.839, 0.875, and 0.946, respectively (Fig. 7I). This evidence concerns the gene MED8 and metabolic dysfunction-associated steatohepatitis.